back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-15 13:58 Tx date 2023-06-08 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$-752,155.39
-10,745,077 vol $0.07 each |
12,522,906 | |
| Filed 2023-06-15 13:49 Tx date 2023-06-08 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$752,155
+10,745,077 vol $0.07 each |
23,267,983 | |
| Filed 2023-06-15 13:41 Tx date 2023-06-08 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$752,155
+10,745,077 vol $0.07 each |
12,522,906 | |
| Filed 2023-01-25 23:44 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,725
+765,000 vol $0.065 each |
1,569,117 | |
| Filed 2022-10-21 13:27 Tx date 2022-10-20 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$411,000
+2,740,000 vol $0.15 each |
6,511,918 | |
| Filed 2020-12-22 21:24 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-5,183,338 vol |
740,477 | |
| Filed 2020-12-22 21:20 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-5,628,819 vol |
804,117 | |
| Filed 2020-12-22 21:17 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-12,444,800 vol |
1,777,829 | |
| Filed 2020-08-10 21:57 Tx date 2020-08-07 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,500
+3,500,000 vol $0.055 each |
3,771,918 | |
| Filed 2020-07-09 12:05 Tx date 2020-07-06 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$684,807
+7,608,967 vol $0.09 each |
11,422,921 | |
| Filed 2020-07-09 12:02 Tx date 2020-07-06 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$532,627
+7,608,967 vol $0.07 each |
11,258,158 | |
| Filed 2020-06-03 14:11 Tx date 2020-06-01 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
38 - Redemption, retraction, cancellation, repurchase
|
$
-$100,000 vol $100.00 each |
$200,000 | |
| Filed 2020-06-03 13:10 Tx date 2020-06-01 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-243,000 vol |
6,432,936 | |
| Filed 2019-08-31 12:50 Tx date 2019-07-26 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$330,734
+1,787,752 vol $0.185 each |
5,923,815 | |
| Filed 2019-08-31 12:45 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$355,093
+3,550,936 vol $0.10 each |
6,675,936 | |
| Filed 2019-08-31 12:45 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$147,500
+1,475,000 vol $0.10 each |
3,125,000 | |
| Filed 2019-08-31 12:43 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,550,936 vol |
||
| Filed 2019-08-31 12:43 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,475,000 vol |
||
| Filed 2019-08-31 12:08 Tx date 2019-07-26 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+3,575,503 vol |
14,222,629 | |
| Filed 2019-08-30 16:56 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,550,936 vol |
||
| Filed 2019-08-30 16:54 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,475,000 vol |
||
| Filed 2019-08-30 16:56 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,550,936 vol |
5,297,854 | |
| Filed 2019-08-30 16:54 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,475,000 vol |
1,746,918 | |
| Filed 2019-08-30 16:29 Tx date 2018-12-31 |
$SZLS
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-251,817.498
-5,486,220 vol $0.0459 each |
10,647,126 | |
| Filed 2019-01-07 11:04 Tx date 2018-12-31 |
$SZLS
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,486,220 vol |
||
| Filed 2019-01-07 Tx date 2018-12-31 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,486,220 vol |
10,647,126 | |
| Filed 2018-07-03 Tx date 2018-06-28 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,000
+150,000 vol $0.08 each |
1,650,000 | |
| Filed 2018-07-03 Tx date 2018-05-28 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-32,667.32
-33,334 vol $0.98 each |
1,500,000 | |
| Filed 2018-05-25 Tx date 2018-05-22 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$561,770
+7,022,126 vol $0.08 each |
16,133,346 | |
| Filed 2018-05-25 Tx date 2018-05-22 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$421,327
+3,511,063 vol $0.12 each |
4,136,063 | |
| Filed 2018-05-25 Tx date 2018-05-22 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
-$279,656 vol $1.00 each |
$300,000 | |
| Filed 2018-05-25 Tx date 2018-05-22 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
-$148,000 vol $1.00 each |
$0 | |
| Filed 2018-05-17 Tx date 2018-05-15 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$50,000 vol $1.00 each |
$579,656 | |
| Filed 2018-04-04 Tx date 2018-04-02 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+150,000 vol $0.11 each |
1,533,334 | |
| Filed 2018-03-29 Tx date 2018-03-26 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $1.00 each |
$529,656 | |
| Filed 2018-03-11 Tx date 2018-03-08 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$50,000 vol $1.00 each |
$429,656 | |
| Filed 2018-03-06 Tx date 2018-02-26 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $1.00 each |
$379,656 | |
| Filed 2018-03-06 Tx date 2018-02-26 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $1.00 each |
||
| Filed 2017-12-22 Tx date 2017-12-20 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+1,000,000 vol $0.145 each |
1,383,334 | |
| Filed 2017-12-22 Tx date 2017-12-21 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$65,000 vol $1.00 each |
$279,656 | |
| Filed 2017-12-19 Tx date 2017-12-18 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$252,998
+2,023,989 vol $0.125 each |
7,778,822 | |
| Filed 2017-12-19 Tx date 2017-12-18 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$-10.00
-80 vol $0.125 each |
9,111,220 | |
| Filed 2017-12-19 Tx date 2017-10-20 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $1.00 each |
$400,000 | |
| Filed 2017-12-19 Tx date 2017-12-04 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$48,000 vol $1.00 each |
$448,000 | |
| Filed 2017-12-19 Tx date 2017-12-18 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
-$200,000 vol $1.00 each |
$248,000 | |
| Filed 2017-12-19 Tx date 2017-09-15 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-781,250
-1,562,500 vol $0.50 each |
625,000 | |
| Filed 2017-12-19 Tx date 2017-12-18 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$126,585
+1,332,478 vol $0.095 each |
9,111,300 | |
| Filed 2017-12-19 Tx date 2017-12-18 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
-$100,000 vol $1.00 each |
$148,000 | |
| Filed 2017-11-17 Tx date 2017-11-09 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$70,000 vol $1.00 each |
$214,656 | |
| Filed 2017-10-25 Tx date 2017-10-20 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $1.00 each |
$300,000 | |
| Filed 2017-08-31 Tx date 2014-08-07 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-31 Tx date 2017-08-28 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$200,000 vol $1.00 each |
$200,000 | |
| Filed 2017-07-14 Tx date 2017-07-14 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$129,177
+561,642 vol $0.23 each |
5,754,833 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,250
+75,000 vol $0.19 each |
383,334 | |
| Filed 2017-06-12 Tx date 2017-04-26 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-16,001.28
-16,668 vol $0.96 each |
308,334 | |
| Filed 2017-01-03 Tx date 2016-12-30 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-373,145.40
-1,607,000 vol $0.2322 each |
5,193,191 | |
| Filed 2017-01-03 Tx date 2016-12-29 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-217,713.40
-893,000 vol $0.2438 each |
6,800,191 | |
| Filed 2016-09-06 Tx date 2016-06-27 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $100,000 each |
$400,000 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
-$305,344 vol |
$144,656 | |
| Filed 2016-09-06 Tx date 2016-07-12 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
+$50,000 vol |
$450,000 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$400,000
+2,500,000 vol $0.16 each |
7,693,191 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$312,500
+625,000 vol $0.50 each |
2,187,500 | |
| Filed 2016-08-12 Tx date 2016-06-27 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
-$100,000 vol |
$300,000 | |
| Filed 2016-08-12 Tx date 2016-05-16 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-19,001.52
-16,668 vol $1.14 each |
275,002 | |
| Filed 2016-07-05 Tx date 2016-06-30 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,500
+50,000 vol $0.17 each |
341,670 | |
| Filed 2015-12-16 Tx date 2015-12-07 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
11 - Acquisition or disposition carried out privately
|
+$400,000 vol |
$400,000 | |
| Filed 2015-12-16 Tx date 2014-08-07 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Promissory Notes
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-20 Tx date 2015-08-19 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$781,250
+1,562,500 vol $0.50 each |
1,562,500 | |
| Filed 2015-08-20 Tx date 2015-07-08 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-18,996.96
-8,332 vol $2.28 each |
291,670 | |
| Filed 2015-08-20 Tx date 2015-08-19 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+1,562,500 vol $0.32 each |
5,193,191 | |
| Filed 2015-06-02 Tx date 2015-06-01 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-993,997.44
-690,276 vol $1.44 each |
0 | |
| Filed 2015-06-02 Tx date 2015-02-01 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-4,498,096.32
-3,123,678 vol $1.44 each |
690,276 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$GEN
GeneNews Limited |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,000
+50,000 vol $0.32 each |
300,002 |